Blarcamesine is an experimental drug candidate investigated for Alzheimer's disease and other conditions. It is supplied as a pharmaceutical raw material for research and development purposes.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 195615-83-9
ANAVEX2-73 hydrochloride
pharmaceutical raw material
Pramlintide acetate
pharmaceutical raw material
Clascoterone
pharmaceutical raw material
Ibrexafungerp citrate hydrate
pharmaceutical raw material
Ramelteon
pharmaceutical raw material
1-(2,2-diphenyloxolan-3-yl)-N,N-dimethylmethanamine
BOTHKNZTGGXFEQ-UHFFFAOYSA-N
CN(C)CC1CCOC1(C2=CC=CC=C2)C3=CC=CC=C3